EFFICACY OF THE DUPILUMAB 200 MG DOSE EVERY 2 WEEKS IN CHILDREN WITH MODERATE-TO-SEVERE ASTHMA DURING VOYAGE AND EXCURSION

被引：0
|
作者：
Phipatanakul, W. [1 ]
Vogelberg, C. [2 ]
LB, Bacharier [3 ]
Dell, S. D. [4 ]
Altincatal, A. [5 ]
Gall, R. [6 ]
Ledanois, O. [7 ]
Sacks, H. [6 ]
Jacob-Nara, J. A. [8 ]
Deniz, Y. [6 ]
Rowe, P. J. [8 ]
机构：
[1] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA
[2] Techn Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Med Ctr, Nashville, TN USA
[4] BC Childrens Hosp, Vancouver, BC, Canada
[5] Sanofi, Cambridge, MA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Paris, France
[8] Sanofi, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO26
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to-severe type 2 inflammatory asthma by allergen sensitization status
    Phipatanakul, W.
    Papadopoulos, N. G.
    Hernandez-Trujillo, V.
    Hamelmann, E.
    Zeiger, R. S.
    Ducharme, F. M.
    Jain, N.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGOLOGIE, 2022, 45 (08) : 604 - 604
  • [22] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
    Corren, Jonathan
    Castro, Mario
    O'Riordan, Thomas
    Hanania, Nicola A.
    Pavord, Ian D.
    Quirce, Santiago
    Chipps, Bradley E.
    Wenzel, Sally E.
    Thangavelu, Karthinathan
    Rice, Megan S.
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Maroni, Jaman
    Rowe, Paul
    Lu, Yufang
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 516 - 526
  • [23] Dupilumab in children with moderate-to-severe asthma: A cost utility analysis
    Buendia, Jefferson A.
    Patino, Diana G.
    PEDIATRIC PULMONOLOGY, 2022, 57 (10) : 2313 - 2319
  • [24] Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST
    Maspero, Jorge F.
    FitzGerald, John Mark
    Pavord, Ian D.
    Rice, Megan S.
    Maroni, Jaman
    Rowe, Paul J.
    Pirozzi, Gianluca
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    Hardin, Megan
    ALLERGY, 2021, 76 (08) : 2621 - 2624
  • [25] Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
    Jackson, Daniel J.
    Bacharier, Leonard B.
    Phipatanakul, Wanda
    Sher, Lawrence
    Domingo, Christian
    Papadopoulos, Nikolaos
    Modena, Brian
    Li, Ning
    Xia, Changming
    Kamal, Mohamed A.
    Dillon, Myles
    Wolfe, Kelley
    Gall, Rebecca
    Amin, Nikhil
    Mannent, Leda P.
    Laws, Elizabeth
    Rowe, Paul J.
    Jacob -Nara, Juby A.
    Deniz, Yamo
    Lederer, David J.
    Hardin, Megan
    Xu, Christine
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (01) : 44 - +
  • [26] Efficacy of Dupilumab in Pediatric Patients with Uncontrolled, Moderate-to-Severe Asthma With and Without Ongoing Atopic Comorbid Disease: LIBERTY ASTHMA VOYAGE
    Guilbert, T. W.
    Deschildre, A.
    Jackson, D. J.
    Begin, P.
    Zeiger, R. S.
    Szefler, S. J.
    Altincatal, A.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Djandji, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [27] Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction
    Hanania, Nicola A.
    Castro, Mario
    Bateman, Eric
    Pavord, Ian D.
    Papi, Alberto
    FitzGerald, J. Mark
    Maspero, Jorge F.
    Katelaris, Constance H.
    Singh, Dave
    Daizadeh, Nadia
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Laws, Elizabeth
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (02) : 206 - 214.e2
  • [28] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization
    Corren, Jonathan
    Hanania, Nicola A.
    Busse, William W.
    Sher, Lawrence D.
    Altincatal, Arman
    Hardin, Megan
    Mannent, Leda P.
    Amin, Nikhil
    Lederer, David J.
    Soler, Xavier
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (10): : 1020 - 1030
  • [29] Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma
    Papadopoulos, Nikolaos G. G.
    Szefler, Stanley J. J.
    Bacharier, Leonard B. B.
    Maspero, Jorge F. F.
    Domingo, Christian
    Fiocchi, Alessandro
    Lee, Jason K. K.
    Daizadeh, Nadia
    Lederer, David J. J.
    Hardin, Megan
    Gall, Rebecca
    Djandji, Michel
    Siddiqui, Shahid
    Jacob-Nara, Juby A. A.
    Deniz, Yamo
    Rowe, Paul J. J.
    ALLERGY, 2023, 78 (08) : 2157 - 2167
  • [30] The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases
    Shi, Tingting
    Wu, Shuning
    Chen, Rongshan
    Xie, Yaping
    Yin, Genquan
    He, Chunhui
    Liang, Cuiping
    Lu, Gen
    BMC PULMONARY MEDICINE, 2024, 24 (01):
12345